Works matching IS 09395555 AND DT 2021 AND VI 100 AND IP 8

Results: 32
    1
    2

    Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 2031, doi. 10.1007/s00277-021-04574-0
    By:
    • Virk, Harpreet;
    • Rana, Sonia;
    • Sharma, Praveen;
    • Bose, Parveen Lata;
    • Yadav, Diksha Dev;
    • Sachdeva, Man Updesh Singh;
    • Varma, Neelam;
    • Trehan, Amita;
    • Lad, Deepesh;
    • Khadwal, Alka Rani;
    • Malhotra, Pankaj;
    • Sreedharanunni, Sreejesh
    Publication type:
    Article
    3
    4
    5
    6

    Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

    Published in:
    2021
    By:
    • Schuler, Esther;
    • Wagner-Drouet, Eva-Maria;
    • Ajib, Salem;
    • Bug, Gesine;
    • Crysandt, Martina;
    • Dressler, Sabine;
    • Hausmann, Andreas;
    • Heidenreich, Daniela;
    • Hirschbühl, Klaus;
    • Hoepting, Matthias;
    • Jost, Edgar;
    • Kaivers, Jennifer;
    • Klein, Stefan;
    • Koldehoff, Michael;
    • Kordelas, Lambros;
    • Kriege, Oliver;
    • Müller, Lutz P.;
    • Rautenberg, Christina;
    • Schaffrath, Judith;
    • Schmid, Christoph
    Publication type:
    Correction Notice
    7
    8
    9

    Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 2043, doi. 10.1007/s00277-021-04548-2
    By:
    • Zimmermann, Heiner;
    • Nitsche, Mirko;
    • Pott, Christiane;
    • Reinke, Petra;
    • Babel, Nina;
    • Hermann, Robert M.;
    • Hauser, Ingeborg A.;
    • Hahn, Dennis;
    • Ritgen, Matthias;
    • Pietschmann, Claudia;
    • Klapper, Wolfram;
    • Anagnostopoulos, Ioannis;
    • Trappe, Ralf U.
    Publication type:
    Article
    10
    11

    Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 1921, doi. 10.1007/s00277-021-04532-w
    By:
    • Batista, Jéssica V. G. F.;
    • Pereira-Martins, Diego A.;
    • Falcão, Diego A.;
    • Domingos, Igor F.;
    • Arcanjo, Gabriela S.;
    • Hatzlhofer, Betânia L.;
    • Weinhäuser, Isabel;
    • Batista, Thais H. C.;
    • Cardoso, Pablo R. G.;
    • dos Anjos, Ana C.;
    • Hazin, Manuela F.;
    • Pitta, Maira G. R.;
    • Costa, Fernando F.;
    • Araujo, Aderson S.;
    • Lucena-Araujo, Antonio R.;
    • Bezerra, Marcos A.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 2051, doi. 10.1007/s00277-021-04407-0
    By:
    • Lee, Ji Hyun;
    • Park, Yong;
    • Kang, Ka-Won;
    • Lee, Je-Jung;
    • Lee, Ho Sup;
    • Eom, Hyeon-Seok;
    • Do, Young Rok;
    • Kim, Jin Seok;
    • Yoon, Sung-Soo;
    • Shin, Dong-Yeop;
    • Koh, Youngil;
    • Kim, Ki-Hyun;
    • Lee, Won Sik;
    • Jo, Jae-Cheol;
    • Lee, Yoo Jin;
    • Lee, Ji Yun;
    • Kim, Dae Sik;
    • Shim, Hyeok;
    • Chang, Myung Hee;
    • Kim, Sung-Hyun
    Publication type:
    Article
    18

    Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 2005, doi. 10.1007/s00277-020-04392-w
    By:
    • Caocci, Giovanni;
    • Mulas, Olga;
    • Capodanno, Isabella;
    • Bonifacio, Massimiliano;
    • Annunziata, Mario;
    • Galimberti, Sara;
    • Luciano, Luigiana;
    • Tiribelli, Mario;
    • Martino, Bruno;
    • Castagnetti, Fausto;
    • Binotto, Gianni;
    • Pregno, Patrizia;
    • Stagno, Fabio;
    • Abruzzese, Elisabetta;
    • Bocchia, Monica;
    • Gozzini, Antonella;
    • Albano, Francesco;
    • Fozza, Claudio;
    • Luzi, Debora;
    • Efficace, Fabio
    Publication type:
    Article
    19
    20
    21

    Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 1995, doi. 10.1007/s00277-020-04360-4
    By:
    • Janusz, Kamila;
    • Izquierdo, Marta Martín;
    • Cadenas, Félix López;
    • Ramos, Fernando;
    • Sánchez, Jesús María Hernández;
    • Lumbreras, Eva;
    • Robledo, Cristina;
    • del Real, Javier Sánchez;
    • Caballero, Juan Carlos;
    • Collado, Rosa;
    • Bernal, Teresa;
    • Pedro, Carme;
    • Insunza, Andrés;
    • de Paz, Raquel;
    • Xicoy, Blanca;
    • Salido, Eduardo;
    • García, Joaquín Sánchez;
    • Mínguez, Sandra Santos;
    • García, Cristina Miguel;
    • Muñoz, Ana María Simón
    Publication type:
    Article
    22

    Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 2023, doi. 10.1007/s00277-020-04357-z
    By:
    • Mian, Afsar Ali;
    • Haberbosch, Isabella;
    • Khamaisie, Hazem;
    • Agbarya, Abed;
    • Pietsch, Larissa;
    • Eshel, Elizabeh;
    • Najib, Dally;
    • Chiriches, Claudia;
    • Ottmann, Oliver Gerhard;
    • Hantschel, Oliver;
    • Biondi, Ricardo M.;
    • Ruthardt, Martin;
    • Mahajna, Jamal
    Publication type:
    Article
    23
    24
    25
    26

    The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 1975, doi. 10.1007/s00277-020-04314-w
    By:
    • Hosokawa, Kohei;
    • Ishiyama, Ken;
    • Ikemoto, Toshiyuki;
    • Sugimori, Chiharu;
    • Noji, Hideyoshi;
    • Shichishima, Tsutomu;
    • Obara, Naoshi;
    • Chiba, Shigeru;
    • Ninomiya, Haruhiko;
    • Nguyen, Mai Anh Thi;
    • Shirasugi, Yukari;
    • Nakamura, Yoshihiko;
    • Ando, Kiyoshi;
    • Ueda, Yasutaka;
    • Yonemura, Yuji;
    • Kawaguchi, Tatsuya;
    • Nishimura, Jun-ichi;
    • Kanakura, Yuzuru;
    • Nakao, Shinji
    Publication type:
    Article
    27
    28
    29
    30
    31
    32